Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Meyer CAL"'
Autor:
Stuparu AD; Atreca Inc., South San Francisco, California., Capri JR; AstraZeneca, Chemical Biology Group, Waltham, Massachusetts., Meyer CAL; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California., Le TM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California., Evans-Axelsson SL; Department of Translational Medicine, Division of Urological Cancers, Skåne University Hospital Malmö, Lund University, Lund, Sweden., Current K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California., Lennox M; School of Electronics, Electrical Engineering, and Computer Science, Queen's University Belfast, Belfast, United Kingdom., Mona CE; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany., Calais J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Eiber M; Clinic for Nuclear Medicine, Technical University Munich, Munich, Germany., Dahlbom M; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California., Czernin J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Radu CG; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Lückerath K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; klueckerath@mednet.ucla.edu.; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Slavik R; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Jul 01; Vol. 62 (7), pp. 989-995. Date of Electronic Publication: 2020 Dec 04.
Autor:
Stuparu AD; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Meyer CAL; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Evans-Axelsson SL; Department of Translational Medicine, Division of Urological Cancers, Skåne University Hospital Malmö, Lund University, Sweden., Lückerath K; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Wei LH; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Kim W; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Poddar S; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Mona CE; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Dahlbom M; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Girgis MD; Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Radu CG; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Czernin J; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA., Slavik R; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA.
Publikováno v:
Theranostics [Theranostics] 2020 Feb 03; Vol. 10 (6), pp. 2612-2620. Date of Electronic Publication: 2020 Feb 03 (Print Publication: 2020).
Autor:
Radchenko V; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA; Life Science Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada., Mastren T; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Meyer CAL; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Ivanov AS; Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Bryantsev VS; Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Copping R; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Denton D; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Engle JW; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA; Department of Medical Physics, University of Wisconsin, Madison, WI 53705, USA., Griswold JR; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Murphy K; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Wilson JJ; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA; Department of Chemistry&Chemical Biology, Cornell University, Ithaca, NY 14853, USA., Owens A; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Wyant L; Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Birnbaum ER; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Fitzsimmons J; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Medvedev D; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Cutler CS; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Mausner LF; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Nortier MF; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., John KD; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Mirzadeh S; Nuclear Security and Isotope Technology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA., Fassbender ME; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA. Electronic address: mifa@lanl.gov.
Publikováno v:
Talanta [Talanta] 2017 Dec 01; Vol. 175, pp. 318-324. Date of Electronic Publication: 2017 Jul 20.
Autor:
Radchenko V; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Engle JW; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Medvedev DG; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Maassen JM; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Naranjo CM; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Unc GA; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Meyer CAL; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Mastren T; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Brugh M; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Mausner L; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Cutler CS; Collider-Accelerator Department, Brookhaven National Laboratory, Bldg 801, Upton, NY 11973, USA., Birnbaum ER; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., John KD; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Nortier FM; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Fassbender ME; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA. Electronic address: mifa@lanl.gov.
Publikováno v:
Nuclear medicine and biology [Nucl Med Biol] 2017 Jul; Vol. 50, pp. 25-32. Date of Electronic Publication: 2017 Apr 07.
Autor:
Radchenko V; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Meyer CAL; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Engle JW; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Naranjo CM; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Unc GA; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Mastren T; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Brugh M; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Birnbaum ER; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., John KD; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Nortier FM; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA., Fassbender ME; Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA. Electronic address: mifa@lanl.gov.
Publikováno v:
Journal of chromatography. A [J Chromatogr A] 2016 Dec 16; Vol. 1477, pp. 39-46. Date of Electronic Publication: 2016 Nov 24.